(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GSTA5 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1620118 6480464 epigallocatechin gallate results in increased expression of GSTA1 mRNA CTD PMID:25585349 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:1620118 6480464 o, p'-DDT affects the expression of GSTA1 mRNA CTD PMID:18925944 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of GSTA5 mRNA CTD PMID:27840820 1-Cyano-2-hydroxy-3-butene increases expression EXP 6480464 1-cyano-2-hydroxy-3-butene results in increased expression of GSTA5 mRNA, 1-cyano-2-hydroxy-3-butene results in increased expression of GSTA5 protein CTD PMID:11446830 1-Cyano-2-hydroxy-3-butene multiple interactions EXP 6480464 [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 mRNA, [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 protein CTD PMID:11446830 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GSTA5 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GSTA5 mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO RGD:1620118 6480464 Estradiol results in decreased expression of GSTA1 mRNA CTD PMID:19484750 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of GSTA5 mRNA CTD PMID:31119341 1H-imidazole increases expression EXP 6480464 imidazole results in increased expression of GSTA5 mRNA CTD PMID:8951341 1H-pyrazole increases expression ISO RGD:1620118 6480464 pyrazole results in increased expression of GSTA1 mRNA CTD PMID:17945193 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1620118 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GSTA5 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1620118 6480464 Tetrachlorodibenzodioxin affects the expression of GSTA1 mRNA CTD PMID:18343893 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:1620118 6480464 Tetrachlorodibenzodioxin results in increased activity of GSTA1 protein CTD PMID:16243960 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1620118 6480464 AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTA1 mRNA] more ... CTD PMID:16243960 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1344623 6480464 Tetrachlorodibenzodioxin results in increased expression of GSTA5 mRNA CTD PMID:21496263 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1620118 6480464 Tetrachlorodibenzodioxin results in increased expression of GSTA1 mRNA more ... CTD PMID:16243960 more ... 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1620118 6480464 2 more ... CTD PMID:18343893 2,6-di-tert-butyl-4-methylphenol multiple interactions EXP 6480464 Butylated Hydroxytoluene promotes the reaction [GSTA5 protein affects the metabolism of aflatoxin B1-2 more ... CTD PMID:8198522 2,6-di-tert-butyl-4-methylphenol increases activity EXP 6480464 Butylated Hydroxytoluene results in increased activity of GSTA5 protein CTD PMID:9328168 2-acetamidofluorene increases expression ISO RGD:1620118 6480464 2-Acetylaminofluorene results in increased expression of GSTA1 mRNA CTD PMID:17317680 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of GSTA5 mRNA CTD PMID:14600272 2-tert-butylhydroquinone increases expression EXP 6480464 2-tert-butylhydroquinone results in increased expression of GSTA5 mRNA CTD PMID:20650352 2-tert-butylhydroquinone increases activity ISO RGD:1620118 6480464 2-tert-butylhydroquinone results in increased activity of GSTA1 protein CTD PMID:15627257 2-tert-butylhydroquinone increases expression ISO RGD:1620118 6480464 2-tert-butylhydroquinone results in increased expression of GSTA1 mRNA CTD PMID:15627257 more ... 2-tert-butylhydroquinone multiple interactions ISO RGD:1620118 6480464 Tetradecanoylphorbol Acetate promotes the reaction [2-tert-butylhydroquinone results in increased expression of GSTA1 mRNA] CTD PMID:7568053 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1620118 6480464 [3 more ... CTD PMID:24378064 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin analog results in decreased expression of GSTA5 protein CTD PMID:26597043 3-methylcholanthrene decreases expression ISO RGD:1620118 6480464 Methylcholanthrene results in decreased expression of GSTA1 mRNA CTD PMID:23712962 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of GSTA5 mRNA CTD PMID:19695238 3H-1,2-dithiole-3-thione multiple interactions ISO RGD:1620118 6480464 NFE2L2 gene mutant form inhibits the reaction [1 more ... CTD PMID:18367636 , PMID:7568053 3H-1,2-dithiole-3-thione increases expression ISO RGD:1620118 6480464 1, 2-dithiol-3-thione results in increased expression of GSTA1 mRNA CTD PMID:18367636 , PMID:7568053 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-N-methyl-N-nitrosamino-1-3-pyridyl-1-butanone results in increased expression of GSTA5 mRNA CTD PMID:14600272 4-hydroxynon-2-enal increases expression ISO RGD:1620118 6480464 4-hydroxy-2-nonenal results in increased expression of GSTA1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1620118 6480464 Fenretinide results in increased expression of GSTA5 mRNA CTD PMID:28973697 5-bromo-2'-deoxyuridine multiple interactions ISO RGD:1620118 6480464 [Bromodeoxyuridine co-treated with furan] results in increased expression of GSTA1 mRNA CTD PMID:24910943 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA CTD PMID:22687989 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of GSTA5 mRNA CTD PMID:17202759 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GSTA5 mRNA CTD PMID:24780913 acrolein decreases response to substance EXP 6480464 GSTA5 protein results in decreased susceptibility to Acrolein CTD PMID:12076520 acrolein increases expression ISO RGD:1620118 6480464 Acrolein results in increased expression of GSTA1 mRNA CTD PMID:12763045 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of GSTA5 mRNA CTD PMID:28959563 actinomycin D multiple interactions ISO RGD:1620118 6480464 Dactinomycin inhibits the reaction [Lead results in increased expression of GSTA1 mRNA] more ... CTD PMID:16243960 aflatoxin B1 decreases activity EXP 6480464 GSTA5 protein results in decreased activity of Aflatoxin B1 CTD PMID:11346484 aflatoxin B1 decreases expression ISO RGD:1344623 6480464 Aflatoxin B1 results in decreased expression of GSTA5 mRNA CTD PMID:21641981 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GSTA5 mRNA CTD PMID:14600272 more ... aflatoxin B1 decreases response to substance EXP 6480464 GSTA5 protein results in decreased susceptibility to Aflatoxin B1 CTD PMID:12388831 more ... aflatoxin B1 exo-8,9-epoxide multiple interactions EXP 6480464 [GSTA3 protein binds to GSTA5 protein] which affects the metabolism of and results in decreased activity of aflatoxin B1-2 more ... CTD PMID:10085232 more ... aflatoxin B1 exo-8,9-epoxide affects metabolic processing EXP 6480464 GSTA5 protein affects the metabolism of aflatoxin B1-2, 3-oxide CTD PMID:12388831 more ... alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of GSTA5 mRNA CTD PMID:17785943 aminoguanidine multiple interactions ISO RGD:1620118 6480464 pimagedine inhibits the reaction [Spermidine results in increased expression of GSTA1 mRNA] CTD PMID:12763045 angelica lactone increases expression ISO RGD:1620118 6480464 angelica lactone results in increased expression of GSTA1 protein CTD PMID:11309284 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of GSTA5 mRNA CTD PMID:23038007 antimycin A increases expression ISO RGD:1620118 6480464 Antimycin A results in increased expression of GSTA1 mRNA CTD PMID:19304788 arsenite(3-) increases expression ISO RGD:1620118 6480464 arsenite results in increased expression of GSTA1 mRNA CTD PMID:19933842 Azaspiracid decreases expression ISO RGD:1344623 6480464 azaspiracid results in decreased expression of GSTA5 mRNA CTD PMID:28939011 benzo[a]pyrene decreases expression ISO RGD:1344623 6480464 Benzoapyrene results in decreased expression of GSTA5 mRNA CTD PMID:22316170 benzo[a]pyrene multiple interactions ISO RGD:1620118 6480464 [Benzoapyrene co-treated with sodium bichromate] results in decreased expression of GSTA1 mRNA more ... CTD PMID:11961136 more ... benzo[a]pyrene increases expression ISO RGD:1620118 6480464 Benzoapyrene results in increased expression of GSTA1 mRNA CTD PMID:21569818 more ... benzo[a]pyrene increases methylation ISO RGD:1344623 6480464 Benzoapyrene results in increased methylation of GSTA5 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I multiple interactions ISO RGD:1620118 6480464 GSTA1 protein affects the metabolism of and results in decreased susceptibility to 7 more ... CTD PMID:12557262 benzoquinones increases expression ISO RGD:1620118 6480464 Benzoquinones analog results in increased expression of GSTA1 protein CTD PMID:21651925 benzotriazole increases expression EXP 6480464 benzotriazole results in increased expression of GSTA5 mRNA CTD PMID:8951341 benzyl isothiocyanate increases expression EXP 6480464 benzyl isothiocyanate results in increased expression of GSTA5 protein CTD PMID:9794803 benzylideneacetone multiple interactions ISO RGD:1620118 6480464 Tetradecanoylphorbol Acetate promotes the reaction [benzylideneacetone results in increased expression of GSTA1 mRNA] CTD PMID:7568053 benzylideneacetone increases expression ISO RGD:1620118 6480464 benzylideneacetone results in increased expression of GSTA1 mRNA CTD PMID:7568053 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of GSTA5 mRNA, beta-Naphthoflavone results in increased expression of GSTA5 protein CTD PMID:19695238 more ... beta-naphthoflavone increases expression ISO RGD:1620118 6480464 beta-Naphthoflavone results in increased expression of GSTA1 protein CTD PMID:2049074 beta-naphthoflavone multiple interactions ISO RGD:1620118 6480464 Lipopolysaccharides inhibits the reaction [beta-Naphthoflavone results in increased expression of GSTA1 mRNA] CTD PMID:15627257 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA, isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA] CTD PMID:18164116 , PMID:20045035 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of GSTA5 mRNA CTD PMID:23292798 bifenthrin increases expression ISO RGD:1620118 6480464 bifenthrin results in increased expression of GSTA1 mRNA CTD PMID:26071804 , PMID:27916261 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GSTA5 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:1620118 6480464 bisphenol A results in increased expression of GSTA1 protein CTD PMID:16284450 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GSTA5 gene CTD PMID:28505145 bisphenol A decreases expression ISO RGD:1344623 6480464 bisphenol A results in decreased expression of GSTA5 mRNA CTD PMID:24214726 bisphenol A multiple interactions ISO RGD:1620118 6480464 [potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA, [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA] CTD PMID:27082013 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GSTA5 mRNA CTD PMID:25181051 , PMID:30903817 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of GSTA5 mRNA CTD PMID:17538237 butanal decreases expression ISO RGD:1344623 6480464 butyraldehyde results in decreased expression of GSTA5 mRNA CTD PMID:26079696 butylated hydroxyanisole multiple interactions EXP 6480464 Butylated Hydroxyanisole promotes the reaction [GSTA5 protein affects the metabolism of aflatoxin B1-2 more ... CTD PMID:8198522 butylated hydroxyanisole increases expression ISO RGD:1620118 6480464 Butylated Hydroxyanisole results in increased expression of GSTA1 mRNA, Butylated Hydroxyanisole results in increased expression of GSTA1 protein CTD PMID:11309284 more ... butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of GSTA5 protein CTD PMID:9794803 cadmium atom increases expression ISO RGD:1620118 6480464 Cadmium results in increased expression of GSTA1 mRNA CTD PMID:16517059 , PMID:24067728 cadmium dichloride increases expression ISO RGD:1620118 6480464 Cadmium Chloride results in increased expression of GSTA1 mRNA CTD PMID:16517059 more ... cafestol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTA5 protein] more ... CTD PMID:11346484 more ... cafestol multiple interactions ISO RGD:1620118 6480464 [cafestol co-treated with kahweol palmitate] results in increased expression of GSTA1 protein CTD PMID:11309284 captan increases expression ISO RGD:1620118 6480464 Captan results in increased expression of GSTA1 mRNA CTD PMID:31558096 carbon nanotube increases expression ISO RGD:1620118 6480464 Nanotubes, Carbon analog results in increased expression of GSTA1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1620118 6480464 Nanotubes, Carbon results in decreased expression of GSTA1 mRNA CTD PMID:25620056 carbon nanotube affects expression ISO RGD:1620118 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of GSTA5 mRNA CTD PMID:18172885 chlorambucil decreases response to substance EXP 6480464 GSTA5 protein results in decreased susceptibility to Chlorambucil CTD PMID:12076520 chlordecone affects expression ISO RGD:1620118 6480464 Chlordecone affects the expression of GSTA1 mRNA CTD PMID:29980752 chlorogenic acid increases activity ISO RGD:1620118 6480464 Chlorogenic Acid results in increased activity of GSTA1 protein CTD PMID:15944151 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of GSTA5 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of GSTA5 mRNA CTD PMID:19440498 ciguatoxin CTX1B affects expression ISO RGD:1620118 6480464 Ciguatoxins affects the expression of GSTA1 mRNA CTD PMID:18353800 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of GSTA5 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:1344623 6480464 [Cisplatin co-treated with panobinostat] affects the expression of GSTA5 mRNA CTD PMID:21791302 clofibrate increases expression ISO RGD:1620118 6480464 Clofibrate results in increased expression of GSTA1 mRNA CTD PMID:22496397 clofibrate multiple interactions ISO RGD:1620118 6480464 PPARA protein affects the reaction [Clofibrate results in increased expression of GSTA1 mRNA] CTD PMID:22496397 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of GSTA5 protein CTD PMID:24386269 copper atom multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTA5 mRNA, [Copper co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA CTD PMID:20302851 copper atom decreases expression ISO RGD:1620118 6480464 Copper results in decreased expression of GSTA1 mRNA CTD PMID:16243960 copper atom multiple interactions ISO RGD:1620118 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide promotes the reaction [Copper results in decreased expression of GSTA1 mRNA]] more ... CTD PMID:16243960 copper atom increases activity ISO RGD:1620118 6480464 Copper results in increased activity of GSTA1 protein CTD PMID:16243960 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTA5 mRNA, [Copper co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA CTD PMID:20302851 copper(0) decreases expression ISO RGD:1620118 6480464 Copper results in decreased expression of GSTA1 mRNA CTD PMID:16243960 copper(0) multiple interactions ISO RGD:1620118 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide promotes the reaction [Copper results in decreased expression of GSTA1 mRNA]] more ... CTD PMID:16243960 copper(0) increases activity ISO RGD:1620118 6480464 Copper results in increased activity of GSTA1 protein CTD PMID:16243960 copper(II) sulfate decreases expression ISO RGD:1344623 6480464 Copper Sulfate results in decreased expression of GSTA5 mRNA CTD PMID:19549813 coumarin increases expression EXP 6480464 coumarin results in increased expression of GSTA5 protein CTD PMID:9794803 coumarin increases expression ISO RGD:1620118 6480464 coumarin results in increased expression of GSTA1 protein CTD PMID:11309284 curcumin increases expression EXP 6480464 Curcumin results in increased expression of GSTA5 mRNA CTD PMID:18299980 cycloheximide decreases expression ISO RGD:1620118 6480464 Cycloheximide results in decreased expression of GSTA1 mRNA CTD PMID:16243960 cycloheximide multiple interactions ISO RGD:1620118 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Lead results in increased expression of GSTA1 mRNA]] more ... CTD PMID:16243960 cypermethrin increases expression ISO RGD:1620118 6480464 cypermethrin results in increased expression of GSTA1, cypermethrin results in increased expression of GSTA1 mRNA CTD PMID:32214279 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA, [cyproconazole co-treated with epoxiconazole] results in increased expression of GSTA5 mRNA CTD PMID:29038839 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of GSTA5 mRNA CTD PMID:29038839 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of GSTA5 mRNA CTD PMID:23640034 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of GSTA5 mRNA CTD PMID:23914054 Deoxycorticosterone acetate multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GSTA5 mRNA CTD PMID:22228705 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of GSTA5 mRNA CTD PMID:21146967 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of GSTA5 mRNA, allyl sulfide results in increased expression of GSTA5 protein CTD PMID:19695238 , PMID:8627517 diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of GSTA5 mRNA CTD PMID:20650352 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of GSTA5 mRNA CTD PMID:17452286 diazinon increases expression EXP 6480464 Diazinon results in increased expression of GSTA5 mRNA CTD PMID:19440498 dichloroacetic acid increases expression ISO RGD:1620118 6480464 Dichloroacetic Acid results in increased expression of GSTA1 mRNA CTD PMID:28962523 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of GSTA5 protein CTD PMID:25772430 diclofenac multiple interactions EXP 6480464 [Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GSTA5 protein CTD PMID:25772430 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of GSTA5 mRNA CTD PMID:19440498 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of GSTA5 mRNA CTD PMID:19440498 diethyl malate multiple interactions ISO RGD:1620118 6480464 S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSTA1 mRNA] CTD PMID:24814887 diethyl malate affects expression ISO RGD:1620118 6480464 diethyl malate affects the expression of GSTA1 mRNA CTD PMID:24814887 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of GSTA5 protein CTD PMID:9794803 dimercaprol increases expression ISO RGD:1620118 6480464 Dimercaprol results in increased expression of GSTA1 mRNA CTD PMID:7568053 dimercaprol multiple interactions ISO RGD:1620118 6480464 Tetradecanoylphorbol Acetate promotes the reaction [Dimercaprol results in increased expression of GSTA1 mRNA] CTD PMID:7568053 diuron increases expression EXP 6480464 Diuron results in increased expression of GSTA5 mRNA CTD PMID:21551480 doramapimod increases expression ISO RGD:1620118 6480464 BIRB 796 results in increased expression of GSTA1 mRNA CTD PMID:21328587 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of GSTA5 protein CTD PMID:28818578 elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of GSTA5 mRNA, Selenium deficiency results in increased expression of GSTA5 protein CTD PMID:9331086 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GSTA5 mRNA CTD PMID:29391264 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA, [cyproconazole co-treated with epoxiconazole] results in increased expression of GSTA5 mRNA CTD PMID:29038839 ethanol multiple interactions ISO RGD:1620118 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of GSTA1 mRNA CTD PMID:30517762 ethoxyquin increases expression EXP 6480464 Ethoxyquin results in increased expression of GSTA5 mRNA, Ethoxyquin results in increased expression of GSTA5 protein CTD PMID:1637297 more ... ethoxyquin increases expression ISO RGD:1620118 6480464 Ethoxyquin results in increased expression of GSTA1 protein CTD PMID:11309284 ethoxyquin increases activity EXP 6480464 Ethoxyquin results in increased activity of GSTA5 protein CTD PMID:9328168 ethoxyquin multiple interactions EXP 6480464 Ethoxyquin promotes the reaction [GSTA5 protein affects the metabolism of aflatoxin B1-2 more ... CTD PMID:8198522 etofenprox multiple interactions EXP 6480464 [ethofenprox co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA CTD PMID:22467020 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA CTD PMID:18253720 , PMID:18775883 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of GSTA5 mRNA CTD PMID:17264098 , PMID:18775883 fipronil increases expression EXP 6480464 fipronil results in increased expression of GSTA5 mRNA CTD PMID:23962444 folpet increases expression ISO RGD:1620118 6480464 folpet results in increased expression of GSTA1 mRNA CTD PMID:31558096 furan increases methylation EXP 6480464 furan results in increased methylation of GSTA5 gene CTD PMID:22079235 furan multiple interactions ISO RGD:1620118 6480464 [Bromodeoxyuridine co-treated with furan] results in increased expression of GSTA1 mRNA CTD PMID:24910943 furan increases expression ISO RGD:1620118 6480464 furan results in increased expression of GSTA1 mRNA CTD PMID:24183702 , PMID:24910943 furan increases expression EXP 6480464 furan results in increased expression of GSTA5 mRNA CTD PMID:25539665 , PMID:26194646 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of GSTA5 mRNA CTD PMID:17785943 genistein increases expression ISO RGD:1620118 6480464 Genistein results in increased expression of GSTA1 mRNA CTD PMID:32186404 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of GSTA5 mRNA CTD PMID:15345336 GW 4064 increases expression ISO RGD:1620118 6480464 GW 4064 results in increased expression of GSTA1 mRNA CTD PMID:26655953 hydrogen peroxide decreases response to substance EXP 6480464 GSTA5 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:12076520 hydrogen peroxide increases expression ISO RGD:1620118 6480464 Hydrogen Peroxide results in increased expression of GSTA1 mRNA CTD PMID:31696622 hydrogen peroxide affects expression ISO RGD:1344623 6480464 Hydrogen Peroxide affects the expression of GSTA5 mRNA CTD PMID:20044591 indole-3-methanol increases activity EXP 6480464 indole-3-carbinol results in increased activity of GSTA5 protein CTD PMID:9328168 indole-3-methanol increases expression ISO RGD:1620118 6480464 indole-3-carbinol results in increased expression of GSTA1 protein CTD PMID:11309284 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of GSTA5 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 mRNA more ... CTD PMID:11446830 , PMID:22129741 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of GSTA5 more ... CTD PMID:11446830 more ... indometacin increases expression EXP 6480464 Indomethacin results in increased expression of GSTA5 mRNA CTD PMID:18299717 iron atom multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTA5 mRNA CTD PMID:20302851 iron atom decreases expression ISO RGD:1620118 6480464 Iron results in decreased expression of GSTA1 protein CTD PMID:11755321 iron atom increases expression ISO RGD:1620118 6480464 Iron results in increased expression of GSTA1 mRNA, Iron results in increased expression of GSTA1 protein CTD PMID:11755321 iron(0) multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTA5 mRNA CTD PMID:20302851 iron(0) increases expression ISO RGD:1620118 6480464 Iron results in increased expression of GSTA1 mRNA, Iron results in increased expression of GSTA1 protein CTD PMID:11755321 iron(0) decreases expression ISO RGD:1620118 6480464 Iron results in decreased expression of GSTA1 protein CTD PMID:11755321 isopimpinellin increases expression ISO RGD:1620118 6480464 isopimpinellin results in increased expression of GSTA1 mRNA CTD PMID:18692084 isothiocyanate increases expression ISO RGD:1620118 6480464 Isothiocyanates results in increased expression of GSTA1 protein CTD PMID:15570060 kahweol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTA5 protein] more ... CTD PMID:11346484 more ... L-ascorbic acid multiple interactions ISO RGD:1620118 6480464 Ascorbic Acid promotes the reaction [sodium arsenite results in increased expression of GSTA1 mRNA] CTD PMID:16517059 L-cysteine affects expression EXP 6480464 Cysteine affects the expression of GSTA5 mRNA CTD PMID:11040448 L-methionine affects expression EXP 6480464 Methionine affects the expression of GSTA5 mRNA CTD PMID:11040448 L-selenocysteine increases expression EXP 6480464 Selenocysteine results in increased expression of GSTA5 mRNA CTD PMID:12034368 lead(0) increases expression ISO RGD:1620118 6480464 Lead results in increased expression of GSTA1 mRNA CTD PMID:16243960 lead(0) multiple interactions ISO RGD:1620118 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Lead results in increased expression of GSTA1 mRNA]] more ... CTD PMID:16243960 lead(2+) increases expression ISO RGD:1620118 6480464 Lead results in increased expression of GSTA1 mRNA CTD PMID:16243960 lead(2+) multiple interactions ISO RGD:1620118 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Lead results in increased expression of GSTA1 mRNA]] more ... CTD PMID:16243960 lipopolysaccharide multiple interactions ISO RGD:1620118 6480464 Lipopolysaccharides inhibits the reaction [beta-Naphthoflavone results in increased expression of GSTA1 mRNA] CTD PMID:15627257 lipopolysaccharide decreases expression ISO RGD:1620118 6480464 Lipopolysaccharides results in decreased expression of GSTA1, Lipopolysaccharides results in decreased expression of GSTA1 mRNA CTD PMID:15627257 Meclizine multiple interactions ISO RGD:1620118 6480464 [Meclizine binds to and results in increased activity of NR1I3 protein] which results in increased expression of GSTA1 mRNA CTD PMID:15272053 melatonin multiple interactions EXP 6480464 [Melatonin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA CTD PMID:20033131 melphalan decreases response to substance EXP 6480464 GSTA5 protein results in decreased susceptibility to Melphalan CTD PMID:12076520 menadione affects expression ISO RGD:1620118 6480464 Vitamin K 3 affects the expression of GSTA5 mRNA CTD PMID:20829426 menadione affects expression ISO RGD:1344623 6480464 Vitamin K 3 affects the expression of GSTA5 mRNA CTD PMID:20044591 mercury atom multiple interactions ISO RGD:1620118 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Mercury results in increased expression of GSTA1 mRNA]] more ... CTD PMID:16243960 , PMID:22579925 mercury atom increases expression ISO RGD:1620118 6480464 Mercury results in increased expression of GSTA1 mRNA CTD PMID:16243960 , PMID:22579925 mercury dichloride multiple interactions ISO RGD:1620118 6480464 Tetradecanoylphorbol Acetate promotes the reaction [Mercuric Chloride results in increased expression of GSTA1 mRNA] CTD PMID:7568053 mercury dichloride increases expression ISO RGD:1620118 6480464 Mercuric Chloride results in increased expression of GSTA1 mRNA, Mercuric Chloride results in increased expression of GSTA1 protein CTD PMID:7568053 , PMID:9434069 mercury(0) increases expression ISO RGD:1620118 6480464 Mercury results in increased expression of GSTA1 mRNA CTD PMID:16243960 , PMID:22579925 mercury(0) multiple interactions ISO RGD:1620118 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Mercury results in increased expression of GSTA1 mRNA]] more ... CTD PMID:16243960 , PMID:22579925 metacetamol increases expression ISO RGD:1620118 6480464 3-hydroxyacetanilide results in increased expression of GSTA1 mRNA CTD PMID:18544908 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of GSTA5 mRNA CTD PMID:25242409 methyl methacrylate increases expression ISO RGD:1620118 6480464 Methylmethacrylate results in increased expression of GSTA1 mRNA CTD PMID:16916219 methylglyoxal increases response to substance EXP 6480464 GSTA5 protein results in increased susceptibility to Pyruvaldehyde CTD PMID:12076520 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTA5 mRNA, Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA] CTD PMID:22129741 N-acetylsphingosine decreases expression EXP 6480464 N-acetylsphingosine results in decreased expression of GSTA5 protein CTD PMID:15155840 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1620118 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Lead results in increased expression of GSTA1 mRNA]] more ... CTD PMID:16243960 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of GSTA5 mRNA CTD PMID:19638242 , PMID:25242409 N-nitrosodiethylamine multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTA5 mRNA more ... CTD PMID:18164116 more ... N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of GSTA5 mRNA CTD PMID:14600272 nickel atom affects expression EXP 6480464 Nickel affects the expression of GSTA5 mRNA CTD PMID:19440498 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of GSTA5 mRNA CTD PMID:19440498 ochratoxin A multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTA5 protein] CTD PMID:17110534 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of GSTA5 protein CTD PMID:17110534 oltipraz increases activity EXP 6480464 oltipraz results in increased activity of GSTA5 protein CTD PMID:8625305 , PMID:9328168 oltipraz multiple interactions ISO RGD:1620118 6480464 [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTA1 mRNA, NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTA1 mRNA] CTD PMID:22496397 oltipraz increases expression ISO RGD:1620118 6480464 oltipraz results in increased expression of GSTA1 mRNA, oltipraz results in increased expression of GSTA1 protein CTD PMID:11309284 , PMID:22496397 oltipraz increases expression EXP 6480464 oltipraz results in increased expression of GSTA5 mRNA, oltipraz results in increased expression of GSTA5 protein CTD PMID:8051171 more ... omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of GSTA5 mRNA CTD PMID:17202759 omeprazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA CTD PMID:22687989 oxfendazole multiple interactions EXP 6480464 [isoquercitrin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA more ... CTD PMID:18754104 , PMID:20033131 oxybenzone decreases expression EXP 6480464 oxybenzone results in decreased expression of GSTA5 mRNA CTD PMID:30316929 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of GSTA5 mRNA, Oxycodone results in increased expression of GSTA5 protein CTD PMID:20487198 ozone increases expression ISO RGD:1620118 6480464 Ozone results in increased expression of GSTA1 mRNA CTD PMID:17095637 , PMID:31626304 panobinostat multiple interactions ISO RGD:1344623 6480464 [Cisplatin co-treated with panobinostat] affects the expression of GSTA5 mRNA CTD PMID:21791302 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of GSTA5 mRNA CTD PMID:17202759 paracetamol affects expression ISO RGD:1620118 6480464 Acetaminophen affects the expression of GSTA1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1620118 6480464 Acetaminophen results in increased expression of GSTA1 mRNA CTD PMID:18544908 more ... paracetamol decreases expression ISO RGD:1620118 6480464 Acetaminophen results in decreased expression of GSTA1 mRNA CTD PMID:16611625 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GSTA5 mRNA CTD PMID:25242409 , PMID:30723492 paraquat increases expression ISO RGD:1620118 6480464 Paraquat results in increased expression of GSTA1 mRNA CTD PMID:16128001 pentanal decreases expression ISO RGD:1344623 6480464 pentanal results in decreased expression of GSTA5 mRNA CTD PMID:26079696 pentane-2,3-dione decreases expression EXP 6480464 2, 3-pentanedione results in decreased expression of GSTA5 mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of GSTA5 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1620118 6480464 perfluorooctane sulfonic acid results in increased expression of GSTA1 mRNA CTD PMID:20936131 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of GSTA5 mRNA CTD PMID:19162173 , PMID:28511854 perfluorooctanoic acid increases expression ISO RGD:1620118 6480464 perfluorooctanoic acid results in increased expression of GSTA1 mRNA, perfluorooctanoic acid results in increased expression of GSTA5 mRNA CTD PMID:18467677 more ... perfluorooctanoic acid multiple interactions ISO RGD:1620118 6480464 [perfluorooctanoic acid co-treated with PPARA] results in decreased expression of GSTA1 mRNA more ... CTD PMID:18467677 more ... phenethyl isothiocyanate increases activity EXP 6480464 phenethyl isothiocyanate results in increased activity of GSTA5 protein CTD PMID:9328168 phenobarbital multiple interactions EXP 6480464 Phenobarbital promotes the reaction [GSTA5 protein affects the metabolism of aflatoxin B1-2 more ... CTD PMID:8198522 phenobarbital increases expression ISO RGD:1620118 6480464 Phenobarbital results in increased expression of GSTA1 mRNA, Phenobarbital results in increased expression of GSTA1 protein CTD PMID:20403969 more ... phenobarbital decreases expression ISO RGD:1344623 6480464 Phenobarbital results in decreased expression of GSTA5 mRNA CTD PMID:19084549 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GSTA5 protein CTD PMID:24090815 phenylarsine oxide increases expression ISO RGD:1620118 6480464 oxophenylarsine results in increased expression of GSTA1 mRNA CTD PMID:7568053 phlorizin decreases expression ISO RGD:1620118 6480464 Phlorhizin results in decreased expression of GSTA5 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1620118 6480464 Tetradecanoylphorbol Acetate promotes the reaction [1 more ... CTD PMID:7568053 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of GSTA5 mRNA CTD PMID:18544911 piperonyl butoxide multiple interactions EXP 6480464 Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of GSTA5 mRNA] CTD PMID:18544911 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of GSTA5 mRNA CTD PMID:19162173 pirinixic acid increases expression ISO RGD:1620118 6480464 pirinixic acid results in increased expression of GSTA1 mRNA CTD PMID:23811191 potassium bromate affects expression ISO RGD:1620118 6480464 potassium bromate affects the expression of GSTA5 mRNA CTD PMID:27082013 potassium bromate multiple interactions ISO RGD:1620118 6480464 [potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA more ... CTD PMID:27082013 potassium chloride multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GSTA5 mRNA CTD PMID:22228705 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1620118 6480464 [Pregnenolone Carbonitrile promotes the reaction [NR1I2 protein binds to GSTA1 gene]] which results in increased expression of GSTA1 mRNA more ... CTD PMID:20693526 , PMID:22496397 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1620118 6480464 Pregnenolone Carbonitrile results in increased expression of GSTA1 mRNA CTD PMID:22496397 prochloraz multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA CTD PMID:29038839 propanal decreases expression ISO RGD:1344623 6480464 propionaldehyde results in decreased expression of GSTA5 mRNA CTD PMID:26079696 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of GSTA5 mRNA CTD PMID:19409404 Propiverine affects binding EXP 6480464 propiverine binds to GSTA5 protein CTD PMID:29273565 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of GSTA5 mRNA CTD PMID:22431067 pyrogallol decreases expression ISO RGD:1620118 6480464 Pyrogallol results in decreased expression of GSTA1 mRNA CTD PMID:18789925 pyrogallol multiple interactions ISO RGD:1620118 6480464 Resveratrol inhibits the reaction [Pyrogallol results in decreased expression of GSTA1 mRNA] CTD PMID:18789925 quercetin affects expression EXP 6480464 Quercetin affects the expression of GSTA5 mRNA CTD PMID:18178720 quercetin affects expression ISO RGD:1620118 6480464 Quercetin affects the expression of GSTA1 mRNA CTD PMID:19270413 quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 [isoquercitrin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA, isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA] CTD PMID:20033131 , PMID:20045035 quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 [isoquercitrin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA, isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA] CTD PMID:20033131 , PMID:20045035 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of GSTA5 mRNA CTD PMID:18299717 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of GSTA5 mRNA CTD PMID:25905778 resveratrol multiple interactions ISO RGD:1620118 6480464 Resveratrol inhibits the reaction [Dietary Fats affects the expression of GSTA1 mRNA], Resveratrol inhibits the reaction [Pyrogallol results in decreased expression of GSTA1 mRNA] CTD PMID:17086191 , PMID:18789925 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of GSTA5 mRNA CTD PMID:28374803 rotenone multiple interactions ISO RGD:1620118 6480464 CEBPB protein affects the reaction [Rotenone results in increased expression of GSTA1 mRNA], DDIT3 protein affects the reaction [Rotenone results in increased expression of GSTA1 mRNA] CTD PMID:19304788 rotenone increases expression ISO RGD:1620118 6480464 Rotenone results in increased expression of GSTA1 mRNA CTD PMID:19304788 , PMID:23186747 selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of GSTA5 mRNA, Selenium deficiency results in increased expression of GSTA5 protein CTD PMID:9331086 silicon dioxide decreases expression ISO RGD:1344623 6480464 Silicon Dioxide analog results in decreased expression of GSTA5 mRNA CTD PMID:25895662 sinigrin increases activity EXP 6480464 sinigrin results in increased activity of GSTA5 protein CTD PMID:9328168 sodium arsenite decreases expression ISO RGD:1620118 6480464 sodium arsenite results in decreased expression of GSTA5 mRNA CTD PMID:31532247 sodium arsenite increases activity ISO RGD:1620118 6480464 sodium arsenite results in increased activity of GSTA1 protein CTD PMID:11979426 sodium arsenite increases expression ISO RGD:1620118 6480464 sodium arsenite results in increased expression of GSTA1 mRNA CTD PMID:11979426 more ... sodium arsenite multiple interactions ISO RGD:1620118 6480464 Ascorbic Acid promotes the reaction [sodium arsenite results in increased expression of GSTA1 mRNA] more ... CTD PMID:16517059 more ... sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GSTA5 protein CTD PMID:29459688 sodium dichromate increases expression ISO RGD:1620118 6480464 sodium bichromate results in increased expression of GSTA1 mRNA CTD PMID:31558096 sodium dichromate multiple interactions ISO RGD:1620118 6480464 [Benzoapyrene co-treated with sodium bichromate] results in decreased expression of GSTA1 mRNA CTD PMID:22613061 spermidine increases expression ISO RGD:1620118 6480464 Spermidine results in increased expression of GSTA1 mRNA CTD PMID:12763045 spermidine multiple interactions ISO RGD:1620118 6480464 pimagedine inhibits the reaction [Spermidine results in increased expression of GSTA1 mRNA] CTD PMID:12763045 stilbene oxide increases expression EXP 6480464 stilbene oxide results in increased expression of GSTA5 protein CTD PMID:9794803 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of GSTA5 mRNA CTD PMID:25905778 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of GSTA5 mRNA CTD PMID:25905778 succimer multiple interactions ISO RGD:1620118 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSTA1 mRNA CTD PMID:21641980 sulfasalazine increases expression EXP 6480464 Sulfasalazine results in increased expression of GSTA5 mRNA CTD PMID:17202759 sulfasalazine increases expression ISO RGD:1620118 6480464 Sulfasalazine results in increased expression of GSTA1 mRNA CTD PMID:31830553 sulforaphane multiple interactions ISO RGD:1620118 6480464 NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GSTA1 mRNA], Tetradecanoylphorbol Acetate promotes the reaction [sulforafan results in increased expression of GSTA1 mRNA] CTD PMID:20932822 , PMID:7568053 sulforaphane increases expression ISO RGD:1620118 6480464 sulforafan results in increased expression of GSTA1 mRNA, sulforafan results in increased expression of GSTA1 protein CTD PMID:11309284 more ... taurine multiple interactions ISO RGD:1620118 6480464 [NR1H4 protein affects the susceptibility to Taurine] which affects the expression of GSTA1 mRNA CTD PMID:32062620 tauroursodeoxycholic acid decreases expression EXP 6480464 tauroursodeoxycholic acid results in decreased expression of GSTA5 mRNA CTD PMID:15885361 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of GSTA5 protein CTD PMID:24090815 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GSTA5 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1620118 6480464 Carbon Tetrachloride results in increased expression of GSTA1 mRNA CTD PMID:29987408 , PMID:31870920 tetrachloromethane affects expression ISO RGD:1620118 6480464 Carbon Tetrachloride affects the expression of GSTA1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1620118 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of GSTA1 mRNA CTD PMID:30517762 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GSTA5 mRNA CTD PMID:31150632 thiazoles increases expression EXP 6480464 Thiazoles results in increased expression of GSTA5 mRNA CTD PMID:8951341 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GSTA5 mRNA CTD PMID:23411599 , PMID:25242409 titanium dioxide decreases expression ISO RGD:1620118 6480464 titanium dioxide results in decreased expression of GSTA1 mRNA CTD PMID:23557971 , PMID:27760801 toluene affects expression EXP 6480464 Toluene affects the expression of GSTA5 mRNA CTD PMID:18653662 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of GSTA5 mRNA CTD PMID:19409404 triazines multiple interactions ISO RGD:1620118 6480464 Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of GSTA1 mRNA] CTD PMID:27469509 triazoles increases expression EXP 6480464 Triazoles results in increased expression of GSTA5 mRNA CTD PMID:8951341 tributylstannane increases expression ISO RGD:1620118 6480464 tributyltin results in increased expression of GSTA1 mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GSTA5 mRNA CTD PMID:19448997 trichloroethene increases expression ISO RGD:1620118 6480464 Trichloroethylene results in increased expression of GSTA1 mRNA CTD PMID:28973375 trimethylarsine oxide increases expression ISO RGD:1620118 6480464 trimethylarsine oxide results in increased expression of GSTA1 mRNA CTD PMID:26144063 triphenyl phosphate decreases expression ISO RGD:1620118 6480464 triphenyl phosphate results in decreased expression of GSTA1 mRNA CTD PMID:26183808 triphenyl phosphate increases expression ISO RGD:1620118 6480464 triphenyl phosphate results in increased expression of GSTA1 mRNA CTD PMID:26049154 tris(2-butoxyethyl) phosphate increases expression ISO RGD:1620118 6480464 tris2-butoxyethyl phosphate results in increased expression of GSTA1 mRNA CTD PMID:25808963 tris(2-chloroethyl) phosphate decreases expression ISO RGD:1620118 6480464 trischloroethylphosphate results in decreased expression of GSTA1 mRNA CTD PMID:26183808 tris(2-chloroethyl) phosphate increases expression ISO RGD:1620118 6480464 trischloroethylphosphate results in increased expression of GSTA1 mRNA CTD PMID:26049154 urethane decreases expression ISO RGD:1344623 6480464 Urethane results in decreased expression of GSTA5 mRNA CTD PMID:28818685 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of GSTA5 mRNA CTD PMID:15885361 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GSTA5 mRNA CTD PMID:17202759